Cao, Jiang

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Xia, J., Li, H., Yan, Z., Zhou, D., Wang, Y., Qi, Y., Cao, J., Li, D., Cheng, H., Sang, W., et al. (2023) · Journal of Clinical Oncology

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 94

Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis

Wang, H., Wang, L., Cheng, Y., Xia, Z., Liao, Y., & Cao, J. (2018) · Biomedical Reports

Liver Disease Diagnosis and TreatmentPharmacology and Obesity Treatment

Cited by 70

Expression of the β3 subunit of Na+/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3/AKT pathway

Li, L., Feng, R., Xu, Q., Zhang, F., Liu, T., Cao, J., & Fei, S. (2017) · Oncotarget

Gastric Cancer Management and OutcomesIon Transport and Channel Regulation

Cited by 41

Prevalence and factors associated with anxiety and depressive symptoms among patients hospitalized with hematological malignancies after chimeric antigen receptor T-cell (CAR-T) therapy: A cross-sectional study

Dai, H., Xu, S., Han, J., Li, Z., Cao, J., Hu, T., Li, H., Wei, J., Dou, X., Zhou, F., et al. (2021) · Journal of Affective Disorders

Cancer survivorship and careCAR-T cell therapy research

Cited by 16